Dr. Rashdan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2615
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2013 - 2016- Indiana University School of MedicineResidency, Internal Medicine, 2009 - 2012
Damascus University Faculty of MedicineClass of 2008
Certifications & Licensure
TX State Medical License 2016 - 2026
IN State Medical License 2012 - 2019
Publications & Presentations
PubMed
- Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brie...Yuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, Kenneth D Westover, Sawsan Rashdan
International Journal of Radiation Oncology, Biology, Physics. 2024-08-13 - A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer.Madeleine B Hopson, Sawsan Rashdan
Frontiers in Oncology. 2024-01-01 - Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice.Mitchell S von Itzstein, Yuqiu Yang, Yiqing Wang, David Hsiehchen, Thomas Y Sheffield
Frontiers in Immunology. 2024-01-01
Press Mentions
UT Southwestern: Criteria for Clinical Trials Might Be Too StrictDecember 10th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
